Holly Hunsberger, PhD


Fluroethylnormemantine, a novel NMDA receptor antagonist, for the prevention and treatment of stress-induced maladaptive behavior


Journal article


Chen BK, Luna VM, Shannon ME, Hunsberger HC, Mastrodonato A, Stackmann M, McGowan JC, Rubinstenn G, Denny CA
Biological Psychiatry, 2021

Cite

APA
BK, C., VM, L., ME, S., HC, H., A, M., M, S., … CA, D. (2021). Fluroethylnormemantine, a novel NMDA receptor antagonist, for the prevention and treatment of stress-induced maladaptive behavior. Biological Psychiatry.

Chicago/Turabian
BK, Chen, Luna VM, Shannon ME, Hunsberger HC, Mastrodonato A, Stackmann M, McGowan JC, Rubinstenn G, and Denny CA. “Fluroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior.” Biological Psychiatry (2021).

MLA
BK, Chen, et al. “Fluroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior.” Biological Psychiatry, 2021.